Crossmark

The risk of upper gastrointestinal bleeding associated with concomitant proton pump inhibitor administration during dual antiplatelet therapy with aspirin and prasugrel: a retrospective single-center study

Crossref DOI link: https://doi.org/10.1186/s40780-024-00398-y

Published Online: 2024-11-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ide, Yutaro

Morikawa, Go https://orcid.org/0000-0003-4328-5707
Yoshida, Kyohei

Takano, Yuki

Kubota, Ken

Okazawa, Katsuko

Yasu, Takeo
License Information

Text and Data Mining valid from 2024-11-25

Version of Record valid from 2024-11-25
More Information

Article History

Received: 28 August 2024

Accepted: 14 November 2024

First Online: 25 November 2024

Declarations

:

: This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Hokushin General Hospital (Receipt No. 2023003). Written informed consent was waived and the information was disclosed in an opt-out manner using a document posted in our hospital, where the option to withdraw from this study was also provided.

: Not Applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below